EUVIMEDEUVIMED entdecken
Crossref

The use of pharmacologic agents in the management of temporomandibular joint disorder

Chad Dammling, Shelly Abramowicz, Brian Kinard

Frontiers of Oral and Maxillofacial Medicine · 2022

DOI: 10.21037/fomm-20-37 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers of Oral and Maxillofacial Medicine, 2022. Verfasst von Chad Dammling und 2 weiteren Autor:innen. Die Arbeit wurde bisher 8-mal zitiert (Crossref).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Dammling, C., Abramowicz, S., & Kinard, B. (2022). The use of pharmacologic agents in the management of temporomandibular joint disorder. Frontiers of Oral and Maxillofacial Medicine. https://doi.org/10.21037/fomm-20-37

Vancouver

Dammling C, Abramowicz S, Kinard B. The use of pharmacologic agents in the management of temporomandibular joint disorder. Frontiers of Oral and Maxillofacial Medicine. 2022. doi:10.21037/fomm-20-37

BibTeX
@article{Dammling2022,
  author = {Dammling, Chad and Abramowicz, Shelly and Kinard, Brian},
  title = {The use of pharmacologic agents in the management of temporomandibular joint disorder},
  journal = {Frontiers of Oral and Maxillofacial Medicine},
  year = {2022},
  doi = {10.21037/fomm-20-37}
}
Kostenlos starten →